Image of Michael Wells, PhD from UCLA The California Institute for Regenerative Medicine (CIRM) recently awarded $1.5 million to a new research project led by Michael Wells, PhD, of UCLA, that aims to identify the genetic and molecular risk factors underlying disease-causing viral infections in multiple diverse ancestral populations. Dr. Wells and his team of … Continue reading CIRM invests $1.5 million to UCLA for research identifying risk factors for viral infections
Equipping California nurses with skills to support cell and gene therapy patients
Regenerative medicine is a rapidly evolving field. As more therapies reach commercialization and clinical trial stages, there remains an immediate need to equip direct patient care nurses with skills to support patients on complex clinical trials as well as novel standard-of-care therapies. To address this need and continue efforts to build a regenerative medicine workforce … Continue reading Equipping California nurses with skills to support cell and gene therapy patients
CIRM awards $1.5 million in lung health study for patients with Down Syndrome
Stock image of the Trisomy 21 chromosome The California Institute for Regenerative Medicine (CIRM) recently awarded $1.5 million to Denise Al Alam, PhD, of the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center to support research that aims to understand lung disease in individuals with Trisomy 21, also known as Down Syndrome.Although Trisomy 21 … Continue reading CIRM awards $1.5 million in lung health study for patients with Down Syndrome
CIRM awards $25 million for discovery and clinical research, infrastructure programs
Stock image of a researcher The California Institute for Regenerative Medicine (CIRM) has recently approved awarding $25 million to fund multiple projects across discovery research, clinical research, and infrastructure programs.This funding will support 11 projects under CIRM's Foundation Awards Program, which aims to drive rigorous studies addressing critical basic knowledge gaps in the biology of … Continue reading CIRM awards $25 million for discovery and clinical research, infrastructure programs
State agency launches ‘Championing Change for Sickle Cell in California’ campaign
The California Institute for Regenerative Medicine (CIRM), established by the voters of California, is accelerating research and awareness of Sickle Cell Disease. The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, is proud to announce the launch of "Championing Change for Sickle Cell in California,” a pioneering … Continue reading State agency launches ‘Championing Change for Sickle Cell in California’ campaign
[VIDEO] Igniting innovation: How CIRM is bringing new and diverse perspectives in regenerative medicine
CIRM has produced videos highlighting the experiences of participants from our educational and training programs. At the California Institute for Regenerative Medicine (CIRM), we are passionate about catalyzing growth in regenerative medicine while championing inclusivity. One of CIRM’s strategic goals is to build a diverse and skilled workforce that represents the rich tapestry of California's … Continue reading [VIDEO] Igniting innovation: How CIRM is bringing new and diverse perspectives in regenerative medicine
CIRM approves $2.5 million to establish a Patient Support Program
Hataalii Tiisyatonii Begay (HT) participated in a CIRM-funded clinical trial at UCSF for Artemis-SCID, a condition that can be life-threatening or fatal. Photo courtesy Barbara Ries / UCSF. The California Institute for Regenerative Medicine (CIRM) funds innovative cell and gene therapy research and educational programs to advance regenerative medicine in the Golden State. Just as … Continue reading CIRM approves $2.5 million to establish a Patient Support Program
Identifying a Potential New Stem Cell Treatment for Ovarian Cancer
Stock image of a uterus and ovaries model. The California Institute for Regenerative Medicine (CIRM) has awarded a $5.3 million to Karen Aboody, MD of City of Hope for late-stage preclinical research to develop a neural stem cell mediated treatment for a chemo-resistant, metastatic ovarian cancer. Approximately 22,000 women are diagnosed with ovarian cancer—the most … Continue reading Identifying a Potential New Stem Cell Treatment for Ovarian Cancer
Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases
Symptoms of lupus may include pain or swelling in the joints, extreme fatigue, a butterfly rash on the cheeks and nose, and more. The California Institute for Regenerative Medicine (CIRM) has awarded $7.9 million to Barbara Hickingbottom, MD, of Fate Therapeutics to advance clinical research for FT819, an induced pluripotent stem cell (iPSC)-derived CD19 CAR … Continue reading Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases
CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s
Stock image of Parkinson's disease nerve cells. The California Institute for Regenerative Medicine (CIRM) has approved an $8 million award to Aspen Neuroscience to advance an investigational stem cell-derived dopaminergic neuron replacement therapy for Parkinson’s disease (PD). This individualized potential therapy is being explored in a first-in-human Phase 1/2a clinical trial for patients with moderate … Continue reading CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s
The Stem Cellar 